Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 3 years.
Humacyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 10, 202594.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 8, 2025 | Humacyte Inc. | Open-market purchase | +6,000 | $1.29 | $7,740 |
| Sep 13, 2024 | Humacyte Inc. | Option exercise | +1,200 | $4.09 | $4,908 |
| May 20, 2024 | Humacyte Inc. | Option exercise | +600 | $4.09 | $2,454 |
| May 17, 2024 | Humacyte Inc. | Option exercise | +600 | $4.09 | $2,454 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.